Tag: Global healthcare spending
-
Ortho Regenerative (ORTH.C) targets Q2, 2021 FDA clinical trials to improve surgical outcomes for soft tissue repairs
“2021 will be transformational for the company as we advance the clinical development of our lead product,” added LeDuc.
